HLSQ logo

HLSQ Tessera Defense and Homeland Security Inc

Other OTC · Biotechnology · Healthcare

$0.02
-0.00 (-14.76%)

Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis res…

Market Cap: $48.9Kthlsq.ai

Price

No data yet.

Social Signal Score

44
5d
—
30d
42
2 mentions
—
60d
45
7 mentions
—
90d
46
10 mentions
—
news: 10

Revenue

$332.0K
$0.00$110.7K$221.3K$332.0K
Dec 31Jun 30

Analyst Estimates

FY2025
$-203.50
$-203.50–$-203.50
1 analysts
FY2026
$-58.50
$-58.50–$-58.50
1 analysts
FY2027
$-60.10
$-60.10–$-60.10
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Michael Oster
Sector
Healthcare
Industry
Biotechnology
Employees
20
Beta
1.38
Country
US
thlsq.ai